Literature DB >> 2504599

Intraperitoneal penetration of cefpirome.

J Kavi1, J P Ashby, R Wise, I A Donovan.   

Abstract

Twenty-six patients undergoing elective gastrointestinal surgery received a 1 g intravenous dose of cefpirome before operation. Serum and peritoneal fluid samples, obtained 0.5-7.6 h following administration, were assayed for cefpirome by a microbiological assay. The serum half-life of cefpirome was 2.1 h. The mean concentration of cefpirome in peritoneal fluid 0-2 h after administration was 44.4 micrograms/ml. The half-life of cefpirome in peritoneal fluid was 2 h, with mean concentrations of less than 10 micrograms/ml measured 6 h after administration. The mean percentage of intraperitoneal penetration of cefpirome over the study period was 97.7%. The therapeutic implications are discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2504599     DOI: 10.1007/bf01967480

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  3 in total

1.  The antimicrobial activity of cefpirome, a new cephalosporin.

Authors:  R Wise; J M Andrews; C Cross; L J Piddock
Journal:  J Antimicrob Chemother       Date:  1985-04       Impact factor: 5.790

2.  The penetration of cefoxitin into peritoneal fluid.

Authors:  R Wise; I A Donovan; N S Ambrose; J E Allcock
Journal:  J Antimicrob Chemother       Date:  1981-12       Impact factor: 5.790

3.  Pharmacokinetics and tissue penetration of cefpirome, a new cephalosporin.

Authors:  J Kavi; J M Andrews; J P Ashby; G Hillman; R Wise
Journal:  J Antimicrob Chemother       Date:  1988-12       Impact factor: 5.790

  3 in total
  2 in total

1.  Disposition kinetics and urinary excretion of cefpirome after intravenous injection in buffalo calves.

Authors:  Neetu Rajput; Vinod K Dumka; Harpal S Sandhu
Journal:  J Vet Sci       Date:  2007-03       Impact factor: 1.672

Review 2.  Cefpirome clinical pharmacokinetics.

Authors:  L C Strenkoski; D E Nix
Journal:  Clin Pharmacokinet       Date:  1993-10       Impact factor: 6.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.